Closure of Large Percutaneous Access Sites Using the Prostar XL Percutaneous Vascular Surgery Device

Haas, Patrick; Krajcer, Zvonimir; Diethrich, Edward B.

doi:10.1177/152660289900600209

Cited by 104 publications

(110 citation statements)

References 3 publications

Supporting

Mentioning

105

Contrasting

Unclassified

Order By: Relevance

“…A closure system was introduced for preclosure of the access vessel as previously described. 16 After successful valve implantation, a wire and a pigtail catheter were advanced into the retracted large-bore TAVI sheath…”

Section: Procedural Detailsmentioning

confidence: 99%

Routine Endovascular Treatment With a Stent Graft for Access-Site and Access-Related Vascular Injury in Transfemoral Transcatheter Aortic Valve Implantation

Sedaghat

Neumann

Schahab

et al. 2016

Circ: Cardiovascular Interventions

View full text Add to dashboard Cite

Background-Access-site and access-related vascular injury (ASARVI) is still a major limiting factor in transcatheter aortic valve implantation and affects the outcome of patients. Management strategies for ASARVI include manual compression, stent grafts, and vascular surgery. We hypothesized that the standard use of a self-expanding stent graft for the management of ASARVI is feasible and safe. Methods and Results-Of 407 patients treated by transfemoral transcatheter aortic valve implantation, 110 experienced ASARVI (27.0%). Of these, 96 (87.3%) were managed by the implantation of a self-expanding nitinol stent graft. In the majority of patients, minor vascular complications triggered the implantation of a stent graft (86.5%), mainly because of bleeding (90.6%) and dissection (5.2%) of the common femoral artery with high rates of primary treatment success (97.9%

show abstract

Section: Procedural Detailsmentioning

confidence: 99%

Routine Endovascular Treatment With a Stent Graft for Access-Site and Access-Related Vascular Injury in Transfemoral Transcatheter Aortic Valve Implantation

Sedaghat

Neumann

Schahab

et al. 2016

Circ: Cardiovascular Interventions

View full text Add to dashboard Cite

show abstract

“…Оба устройства могут применяться для осуществления гемостаза после использования устройств c системой доставки до 25F и 21F соответ-ственно [3,6]. В то же время, несмотря на растущий опыт применения ушивающих устройств, не существует единого мнения о безопасности данной методики при эндопротезировании аорты.…”

Section: кардиология и сердечно-сосудистая хирургия 6 2015unclassified

Features of completely percutaneous infrarenal aortic aneurysm stent-grafting

Polyakov¹,

Абугов²,

Charchyan³

et al. 2015

Kardiol. serdechno-sosud. khir.

View full text Add to dashboard Cite

Цель -сравнение пункционной и традиционной методик эндопротезирования брюшной аорты (БА). Материал и методы. В зависимости от используемой методики доступа пациенты разделены на две группы. В 1-ю группу включен 41 пациент с эндопротезированием полностью чрескожным пункционным способом, 2-ю (контрольную) группу составили 97 пациентов с традиционной хирургической техникой доступа к общей бедренной артерии. Критериями оценки вмешательства являлись: технический успех операции и использования ушивающего устройства, сосудистые осложнения, длительность операции и значимые неблагоприятные клинические события. Результаты. Технический успех эндопротезирования достигнут у всех пациентов в обеих группах. Технический успех использования ушивающего устройства наблюдался в 92,7% случаев. Время операции в 1-й группе было статистически достоверно короче по сравнению с контрольной (109±41 мин против 140±54 мин; p=0,001). По другим сравниваемым критериям достоверных различий между группами найдено не было. Заключение. Использование полностью чрескожной пункционной методики эндопротезирования БА сокращает время процедуры, не увеличивая риск развития сосудистых осложнений. Поддержка со стороны сосудистой хирургии обязательна при использовании данной методики. Ключевые слова: эндопротезирование брюшной аорты, неблагоприятная морфология проксимальной шейки.Aim. To compare completely percutaneous and traditional methods of abdominal aortic stent-grafting. Material and methods. Patients were divided into 2 groups depending on technique. Group I included 41 patients who underwent aortic stenting using percutaneous approach; Group II consisted of 97 patients with traditional surgical access to common femoral artery. The intervention was assessed based on technical success of surgery, technical success of suturing device application, vascular complications, duration of surgery and significant adverse clinical events. Results. Technical success of replacement has been achieved in all patients of both groups. Technical success of suturing device use was observed in 92.7% of cases. Duration of surgery was significantly shorter in group I compared with group II (109±41 min vs. 140±54 min; p=0.001). There were no significant differences in other criteria between both groups. Conclusion. Completely percutaneous technique of abdominal aortic stent-grafting reduces procedure time and does not increase the risk of vascular complications. Support from vascular surgery is required when this method is used.

show abstract

“…19,24 Percutaneous Abdominal and Thoracic Aneurysm Repair aneurysm as a less invasive approach with decreased perioperative morbidity and mortality. 25,26 In an effort to produce an even more minimally invasive option, percutaneous EVAR (PEVAR) was pioneered by Haas et al 27 in 1999 using the Prostar XL and was shown at that time to be a safe and effective option for management of the femoral access site. Since that time, both the development of smaller-profile devices and the creation of another option for suture-mediated closure have allowed some centers to adopt a "percutaneous first" approach to EVAR.…”

Section: Closure Devices For Endovascular Interventionsmentioning

confidence: 99%

Percutaneous Interventions in Aortic Disease

Aranson

Watkins

2015

Circulation

View full text Add to dashboard Cite

Closure of Large Percutaneous Access Sites Using the Prostar XL Percutaneous Vascular Surgery Device

Abstract: Maintaining the minimal invasiveness of the percutaneous approach to aortic endografting reduces patient discomfort and permits earlier ambulation and hospital discharge. Initial success seems to be maintained at 1 month, however, longer follow-up will be required.

Cited by 104 publications

References 3 publications

Routine Endovascular Treatment With a Stent Graft for Access-Site and Access-Related Vascular Injury in Transfemoral Transcatheter Aortic Valve Implantation

Routine Endovascular Treatment With a Stent Graft for Access-Site and Access-Related Vascular Injury in Transfemoral Transcatheter Aortic Valve Implantation

Features of completely percutaneous infrarenal aortic aneurysm stent-grafting

Percutaneous Interventions in Aortic Disease

Contact Info

Product

Resources

About